Leica Biosystems Receives FDA 510(k) Clearance to Market a Digital Pathology System for Primary Diagnosis

30 May 2019

Leica Biosystems, the global leader in pathology workflow solutions, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX System for